Intellia Therapeutics, Inc. (LON:0JBU)
7.16
+0.22 (3.17%)
At close: Apr 17, 2025
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of 630.50 million as of April 24, 2025. Its market cap has decreased by -67.20% in one year.
Market Cap
630.50M
Enterprise Value
139.98M
Revenue
46.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.16
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from 537.16M to 630.50M, an increase of 17.38%. That is a compound annual growth rate of 1.80%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 160.68B |
GSK plc | 56.48B |
Haleon | 34.34B |
Smith & Nephew | 8.78B |
ConvaTec Group | 5.22B |
Hikma Pharmaceuticals | 4.20B |
HUTCHMED (China) | 1.98B |
Oxford Nanopore Technologies | 1.15B |